← 產業報告目錄

Medical Grade Chitosan Market, By Origin (Animal Based and Plant Based), By Application (Drug Delivery, Drug Formulation, Gene Delivery, Wound Management, Tissue Engineering, and Disease Diagnosis and Medical Implants), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

出版商 Coherent Market Insights出版日期 2026-07-30頁數 250報告編號 CMR-be49b9fd84

授權報價

Single User Price$4,500 USD
Site License Price$7,000 USD
Enterprisewide Price (Global Site License)$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global medical grade chitosan market is estimated to be valued at USD 430.5 Mn in 2026 and is expected to reach USD 921.9 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033. Medical grade chitosan is a biopolymer obtained from highly refined chitin isolate from crustacean shells or fungi. Due to its Safety, Gelation, and Mucoadhesive capacity in nature, it is a material of choice for wound care, drug delivery, tissue engineering, surgical products, and ophthalmic applications. Its compliance with stringent pharmacopeial and regulatory standards makes it suitable for clinical and in vivo use. The global medical grade chitosan market is driven by increasing demand for sustainable biomaterials, advancements in regenerative medicine, and expanding pharmaceutical research. The growing use of bio-based materials in healthcare, along with ongoing innovation in advanced drug delivery and tissue regeneration technologies, is expected to drive continued market growth during the forecast period. Market Dynamics The global medical grade chitosan market is driven by rising prevalence of chronic wounds, surgical procedures, and regenerative medicine applications, which are increasing demand for advanced wound dressings, hemostatic agents, and tissue engineering materials. Growing adoption of targeted drug delivery systems and supportive regulatory frameworks for biopolymer-based medical products are further accelerating market growth. However, a number of constraints are present in the market, such as high production costs, complex purification processes, raw material variability, and stringent regulatory requirements. Nevertheless, development of fungal-derived chitosan as a shellfish-free alternative, increasing use of chitosan nanoparticles in drug delivery and oncology, and expanding healthcare infrastructure and advanced wound care adoption across emerging economies will offer new opportunities for growth in medical grade chitosan market. Key Features of the Study • This report provides in-depth analysis of the global medical grade chitosan market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global medical grade chitosan market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Primex ehf, KitoZyme S.A., BIO21 Co., Ltd., KIMICA Corporation, NovaMatrix, Yaizu Suisankagaku Industry Co., Ltd., Golden-Shell Pharmaceutical Co., Ltd., Heppe Medical Chitosan GmbH, Ningbo Zhenhai Haixin Biological Products Co., Ltd., and trÅ« Chitosan • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global medical grade chitosan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical grade chitosan market Market Segmentation • Origin Insights (Revenue, USD Mn, 2021 - 2033) o Animal Based o Plant Based • Application Insights (Revenue, USD Mn, 2021 - 2033) o Drug Delivery o Drug Formulation o Gene Delivery o Wound Management o Tissue Engineering o Disease Diagnosis and Medical Implants • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Primex ehf o KitoZyme S.A. o BIO21 Co., Ltd. o KIMICA Corporation o NovaMatrix o Yaizu Suisankagaku Industry Co., Ltd. o Golden-Shell Pharmaceutical Co., Ltd. o Heppe Medical Chitosan GmbH o Ningbo Zhenhai Haixin Biological Products Co., Ltd. o trū Chitosan
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Medical Grade Chitosan Market, By Origin  Global Medical Grade Chitosan Market, By Application  Global Medical Grade Chitosan Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Medical Grade Chitosan Market, By Origin, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Animal Based  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Plant Based  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Medical Grade Chitosan Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Drug Delivery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Drug Formulation  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Gene Delivery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Wound Management  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Tissue Engineering  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Disease Diagnosis and Medical Implants  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Medical Grade Chitosan Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Origin, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 7. Competitive Landscape o Primex ehf  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o KitoZyme S.A.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o BIO21 Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o KIMICA Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o NovaMatrix  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Yaizu Suisankagaku Industry Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Golden-Shell Pharmaceutical Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Heppe Medical Chitosan GmbH  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Ningbo Zhenhai Haixin Biological Products Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o trÅ« Chitosan  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 8. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 9. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Medical Grade Chitosan Market' - Global forecast to 2033
圖表清單 List of Tables & Figures
NA NA

提及公司

o Primex ehfo KitoZyme S.A.o BIO21 Co.Ltd.o KIMICA Corporationo NovaMatrixo Yaizu Suisankagaku Industry Co.Ltd.o Golden-Shell Pharmaceutical Co.Ltd.o Heppe Medical Chitosan GmbHo Ningbo Zhenhai Haixin Biological Products Co.Ltd.o trū Chitosan

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們